cellabs产品代理
cellabs产品代理
Cellabs 用于疟疾的 ELISA 试剂盒已成为临床、研究和血库领域的重要诊断工具。用于 HRP-2 的疟疾抗原 CELISA 正迅速成为药物敏感性研究的首选检测方法，该检测方法的最新改进超灵敏版本现已推出，可用于检测低水平寄生虫血症。用于抗体检测的泛疟疾抗体 CELISA 和用于抗原检测的 Quantimal Ultra-sentisibe pLDH CELISA 正迅速成为大量筛查和血库的首选测试。
Cellabs 产品有三种方便的形式；直接 (DFA) 和间接 (IFA)
Cellabs has specifically targeted those diseases that afflict millions of people worldwide and was one of the first companies to provide diagnostics for malaria, cryptosporidiosis, giardiasis, and chlamydial diseases. Cellabs also has a long history of market leadership with a number of its products, most notably its antibody reagent for Cryptosporidium identification. The Crypto Cel Antibody Reagent became the first IFA reagent approved by the UK Drinking Water Inspectorate to enable water companies to comply with the new Drinking Water Regulations. The Cellabs ELISA kits for malaria has become an important diagnostic tool in the areas of clinical, research and blood banking. Malaria Ag CELISA for HRP-2 is fast becoming the test of choice for drug sensitivity studies, a newly improved ultra-sensitive version of this test for low-level parasitaemia is now available. The Pan Malaria Antibody CELISA for antibody detection and Quantimal Ultra-sentisibe pLDH CELISA for antigen detection are fast becoming the test of choice for high volume screening and blood banking. |
Cellabs products are available in three convenient formats; direct (DFA) and indirect (IFA) immunofluorescent assays,
enzyme-linked immunosorbent assay (ELISA), and rapid diagnostic tests (RDT). All products are manufactured under the international IVD standard ISO13485:2016. We are continuing to develop new products to complement our existing product range through Research and Development.
